News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,021 Results
Type
Article (42307)
Company Profile (294)
Press Release (672420)
Section
Business (210365)
Career Advice (2091)
Deals (36626)
Drug Delivery (106)
Drug Development (83006)
Employer Resources (175)
FDA (16545)
Job Trends (15393)
News (355881)
Policy (33876)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2590)
Accelerated approval (2)
Adcomms (21)
Allergies (82)
Alliances (51366)
ALS (84)
Alzheimer's disease (1357)
Antibody-drug conjugate (ADC) (111)
Approvals (16535)
Artificial intelligence (238)
Autoimmune disease (15)
Automation (14)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (19)
Biosimilars (103)
Biotechnology (188)
Bladder cancer (54)
Brain cancer (26)
Breast cancer (247)
Cancer (1935)
Cardiovascular disease (155)
Career advice (1749)
Career pathing (30)
CAR-T (141)
Cell therapy (394)
Cervical cancer (16)
Clinical research (67138)
Collaboration (768)
Compensation (448)
Complete response letters (24)
COVID-19 (2649)
CRISPR (40)
C-suite (203)
Cystic fibrosis (100)
Data (1854)
Decentralized trials (2)
Denatured (25)
Depression (39)
Diabetes (244)
Diagnostics (6404)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (111)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (81)
Earnings (87718)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114333)
Executive appointments (640)
FDA (17619)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (687)
Gene editing (100)
Generative AI (20)
Gene therapy (284)
GLP-1 (711)
Government (4496)
Grass and pollen (4)
Guidances (48)
Healthcare (18982)
Huntington's disease (23)
IgA nephropathy (21)
Immunology and inflammation (109)
Indications (27)
Infectious disease (2774)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (45)
Intellectual property (81)
Interviews (322)
IPO (16762)
IRA (47)
Job creations (4055)
Job search strategy (1492)
Kidney cancer (9)
Labor market (33)
Layoffs (469)
Leadership (16)
Legal (8367)
Liver cancer (71)
Lung cancer (278)
Lymphoma (130)
Machine learning (2)
Management (59)
Manufacturing (273)
MASH (60)
Medical device (13391)
Medtech (13396)
Mergers & acquisitions (20315)
Metabolic disorders (633)
Multiple sclerosis (66)
NASH (17)
Neurodegenerative disease (76)
Neuropsychiatric disorders (26)
Neuroscience (1830)
NextGen: Class of 2025 (6636)
Non-profit (4524)
Northern California (2346)
Now hiring (36)
Obesity (345)
Opinion (226)
Ovarian cancer (70)
Pain (85)
Pancreatic cancer (76)
Parkinson's disease (128)
Partnered (18)
Patents (201)
Patient recruitment (91)
Peanut (48)
People (58998)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20820)
Phase II (29542)
Phase III (22143)
Pipeline (909)
Podcasts (72)
Policy (118)
Postmarket research (2654)
Preclinical (8804)
Press Release (68)
Prostate cancer (91)
Psychedelics (31)
Radiopharmaceuticals (248)
Rare diseases (364)
Real estate (6251)
Recruiting (67)
Regulatory (22934)
Reports (46)
Research institute (2365)
Resumes & cover letters (358)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (69)
Series A (122)
Series B (76)
Service/supplier (12)
Sickle cell disease (52)
Southern California (2031)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3721)
State (2)
Stomach cancer (13)
Supply chain (60)
The Weekly (45)
United States (20778)
Vaccines (670)
Venture capitalists (37)
Webinars (12)
Weight loss (238)
Women's health (32)
Worklife (15)
Date
Today (121)
Last 7 days (557)
Last 30 days (2849)
Last 365 days (34198)
2025 (7360)
2024 (35769)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32517)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (780)
Alabama (49)
Alaska (7)
Arizona (228)
Arkansas (14)
Asia (40534)
Australia (6495)
California (5384)
Canada (1848)
China (462)
Colorado (241)
Connecticut (255)
Delaware (124)
Europe (86420)
Florida (799)
Georgia (187)
Idaho (57)
Illinois (495)
India (23)
Indiana (293)
Iowa (8)
Japan (138)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (822)
Massachusetts (4096)
Michigan (210)
Minnesota (367)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (55)
New Hampshire (62)
New Jersey (1536)
New Mexico (29)
New York (1551)
North Carolina (917)
North Dakota (7)
Northern California (2346)
Ohio (190)
Oklahoma (14)
Oregon (38)
Pennsylvania (1222)
Puerto Rico (9)
Rhode Island (25)
South America (1160)
South Carolina (17)
South Dakota (1)
Southern California (2031)
Tennessee (92)
Texas (804)
Utah (164)
Virginia (134)
Washington D.C. (57)
Washington State (512)
West Virginia (3)
Wisconsin (50)
715,021 Results for "enanta pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enanta Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
March 17, 2025
·
1 min read
Press Releases
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium
March 12, 2025
·
3 min read
Press Releases
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024
February 10, 2025
·
13 min read
Genetown
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 30, 2024
Enanta Pharmaceuticals, Inc. announced that effective April 29, 2024, the Compensation Committee of Enanta Pharmaceuticals’ Board of Directors granted employment inducement awards to Matthew P. Kowalsky, Enanta’s new Chief Legal Officer.
April 30, 2024
·
3 min read
Press Releases
Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
December 24, 2024
·
3 min read
Press Releases
Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Genetown
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
Enanta Pharmaceuticals, Inc. today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2024 at 7:30 a.m. ET in New York, NY.
May 29, 2024
·
1 min read
Business
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, announced the appointment of Matthew P. Kowalsky, J.D., as Chief Legal Officer.
April 30, 2024
·
4 min read
Genetown
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Enanta Pharmaceuticals, Inc. today announced that data from the company’s SPRINT study of EDP-235 has been accepted for a poster presentation at ESCMID Global 2024 (formerly ECCMID) being held April 27–30 in Barcelona, Spain.
April 17, 2024
·
2 min read
Genetown
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference 2024
Enanta Pharmaceuticals, Inc. announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at the JMP Securities Life Sciences Conference on May 14, 2024 at 10:00 a.m. ET in New York, NY.
May 7, 2024
·
1 min read
1 of 71,503
Next
